Sponsor pipeline

A2 Biotherapeutics Inc. clinical trial pipeline

Get alerts when A2 Biotherapeutics Inc.'s trials change

5 active trials 3 recruiting 11 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 1/2
3
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06051695 A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in… Solid Tumor, Adult Recruiting 2026-06-12
NCT06682793 A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T… Solid Tumor, Adult Recruiting 2025-09-09
NCT05736731 A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in… Solid Tumor, Adult Active, Not Recruiting 2025-04-25
Not specified
NCT04981119 Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell… Solid Tumor, Adult Recruiting 2026-09-25
NCT06885424 A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene… Solid Tumor Cancer Enrolling by Invitation 2026-05-20

Disease areas by active trials, top 10 of 11

Colorectal Cancer (5) · Lung Cancer (5) · Non-Small Cell Lung Cancer (NSCLC) (5) · Pancreatic Cancer (4) · Breast Cancer (3) · Head & Neck Cancer (3) · Kidney Cancer (3) · Mesothelioma (3) · Ovarian Cancer (3) · Triple-Negative Breast Cancer (3)

Get alerts when A2 Biotherapeutics Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free